Russell Investments Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-902
| Closed | -$338K | – | 3140 |
|
|
2020
Q4 | $338K | Buy |
902
+841
| +1,379% | +$315K | ﹤0.01% | 2578 |
|
|
2020
Q3 | $18K | Sell |
61
-163
| -73% | -$48.1K | ﹤0.01% | 3141 |
|
|
2020
Q2 | $83K | Buy |
+224
| New | +$83K | ﹤0.01% | 2921 |
|
|
2017
Q3 | – | Sell |
-314
| Closed | -$350K | – | 2968 |
|
|
2017
Q2 | $350K | Buy |
314
+199
| +173% | +$222K | ﹤0.01% | 2539 |
|
|
2017
Q1 | $63K | Sell |
115
-168
| -59% | -$92K | ﹤0.01% | 2874 |
|
|
2016
Q4 | $172K | Buy |
+283
| New | +$172K | ﹤0.01% | 2744 |
|